From: Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4
Clinicopathological features | Cases | Let-7i-5p expression | t | p | |
---|---|---|---|---|---|
Low | High | ||||
Group | |||||
 ccRCC | 494 | 247 | 247 |  − 12.313 | 0.000 |
 Normal | 70 | 66 | 4 | ||
Age | |||||
 ≥ 60 | 265 | 125 | 140 |  − 1.502 | 0.134 |
 < 60 | 229 | 122 | 107 | ||
Gender | |||||
 Male | 320 | 155 | 165 |  − 0.986 | 0.325 |
 Female | 174 | 92 | 82 | ||
Race | |||||
 White | 426 | 210 | 216 |  − 1.348 | 0.178 |
 Black or African American | 53 | 30 | 23 | ||
Pathological stage | |||||
 III–IV | 204 | 76 | 128 |  − 6.306 | 0.000 |
 I–II | 287 | 171 | 116 | ||
AJCC pathological T | |||||
 T3–T4 | 189 | 69 | 120 |  − 5.892 | 0.000 |
 T1–T2 | 305 | 178 | 127 | ||
AJCC pathological N | |||||
 N1 | 17 | 3 | 14 |  − 2.843 | 0.005 |
 N0 | 220 | 109 | 111 | ||
AJCC pathological M | |||||
 M1 | 78 | 23 | 55 |  − 4.048 | 0.000 |
 M0 | 387 | 209 | 178 | ||
Tumor status | |||||
 With tumor | 144 | 51 | 93 |  − 4.807 | 0.000 |
 Tumor-free | 308 | 178 | 130 | ||
Hemoglobin | |||||
 Low | 244 | 109 | 135 |  − 1.898 | 0.058 |
 Normal | 175 | 98 | 77 |